Questions: Fungal Pathogenesis and Mycotic Infections

Question 1

Why is developing antifungal drugs fundamentally more difficult than developing antibacterial drugs?

• A. Fungi reproduce faster than bacteria, making drug resistance inevitable
• B. Fungi are eukaryotes with cellular machinery nearly identical to human cells, leaving few unique targets to exploit
• C. Fungi have thicker cell walls that prevent drug penetration
• D. Antifungal drugs are chemically unstable and break down before reaching infected tissue

Answer: (B)

The core pharmacological challenge is selectivity. Antibiotics can target bacterial structures absent in human cells — peptidoglycan cell walls, 70S ribosomes, bacterial DNA gyrase. Fungi, being eukaryotes, share the same basic cellular machinery as human cells (80S ribosomes, similar metabolic pathways, cytoskeletal proteins). The few fungal-specific targets — ergosterol in the membrane, β-glucan in the cell wall — are the basis for all major antifungal drug classes (azoles, polyenes, echinocandins), but this limited target space means fewer drug options and more serious side effects.

Question 2

An immunocompetent hiker returning from a trip through the San Joaquin Valley of California develops fever, cough, and chest pain. Fungal infection is suspected. Which pathogen should be considered first, and why?

• A. Candida albicans — most common fungal pathogen worldwide
• B. Coccidioides immitis — an endemic mold in the American Southwest that causes primary infection in healthy hosts
• C. Cryptococcus neoformans — common in soil globally and causes respiratory disease
• D. Aspergillus fumigatus — ubiquitous spore-former that infects the immunocompetent

Answer: (B)

Geography is the critical diagnostic clue for endemic fungi. Coccidioides is endemic to hot, dry soils of the American Southwest (including California's San Joaquin Valley) and is one of the few fungi capable of causing primary respiratory disease in immunocompetent individuals — unlike Candida, Cryptococcus, or Aspergillus, which primarily cause disease in immunocompromised hosts. This is precisely why medical history must include travel and residence history when evaluating suspected fungal infections.

Question 3

Candida albicans and Cryptococcus neoformans primarily cause serious disease in immunocompetent individuals with intact CD4+ T cell responses.

• T. True
• F. False

Answer: False

These are opportunistic fungi — they exploit immunocompromise rather than overcoming intact immunity. Candida, Cryptococcus, and Aspergillus rarely cause life-threatening disease in healthy individuals with functional immune systems. Their clinical significance is largely a consequence of modern medicine: HIV/AIDS (CD4 depletion), chemotherapy (neutropenia), and broad-spectrum antibiotics (disrupting competing bacterial flora) create the immunological vacuums these organisms exploit. This is fundamentally different from endemic fungi like Histoplasma or Coccidioides.

Question 4

Thermal dimorphism — the switch from mold to yeast form at body temperature — is a key virulence mechanism because the yeast form has surface properties and behaviors that help fungi survive inside phagocytes.

• T. True
• F. False

Answer: True

The mold-to-yeast transition at 37°C is not merely a physical response to temperature — it involves wholesale changes in cell wall composition, antigen expression, and metabolic activity. The yeast form of Histoplasma, for example, can survive and replicate inside alveolar macrophages by neutralizing the phagosome's acidic pH, turning the immune cell meant to destroy it into a refuge. The mold form (the environmental form inhaled as spores) is rapidly killed by the same immune cells. Thermal dimorphism is therefore an adaptation specifically for mammalian host survival.

Question 5

Explain why a patient's travel and residence history is often the most important diagnostic clue when evaluating a suspected fungal respiratory infection.

Model answer: Endemic fungi like Histoplasma, Coccidioides, and Blastomyces grow as molds in specific geographic soils — Histoplasma in the Ohio/Mississippi River valleys, Coccidioides in the American Southwest. Humans are exposed by inhaling spores from those soils; the mold form does not spread person-to-person. Without knowing where the patient has lived or traveled, a clinician in an unendemic region may never consider these diagnoses. The clinical presentation of endemic mycoses can mimic bacterial pneumonia, tuberculosis, or lung cancer — travel history is often the only discriminating clue that directs the correct diagnostic workup.

This also illustrates a broader principle in infectious disease: pathogen ecology determines exposure risk. A patient with community-acquired pneumonia unresponsive to antibiotics who recently visited the Southwest should immediately prompt consideration of coccidioidomycosis. Missing this diagnosis leads to inappropriate treatment and delays appropriate antifungal therapy. Geographic epidemiology is as diagnostically important as microbiology in the case of endemic fungi.